Erianin mitigates diabetic cardiomyopathy <i>via</i> adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation

Erianin can effectively alleviate myocardial injury in type 2 diabetic mice by activating the AMPK-Nrf2-HO-1 pathway.

Authors

Institutions

Publication Details

Journal
World Journal of Diabetes
Published
2025-06-13
DOI
https://doi.org/10.4239/wjd.v16.i6.103685
Citations
1
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation

Xuming Dai, Zijiao Quan, Jiahui Chen, Xinyu Liu
1 citations
World Journal of Diabetes
Cardiovascular Function and Risk Factors
1.39
article

Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation

Xuming Dai, Zijiao Quan, Jiahui Chen, Xinyu Liu
article en
1 citations

Abstract

Erianin can effectively alleviate myocardial injury in type 2 diabetic mice by activating the AMPK-Nrf2-HO-1 pathway.

World Journal of DiabetesVol. 16(6)
Wenzhou University (CN), Wenzhou Medical University (CN), Jinzhou Medical University (CN)
Openalex Percentile: Top 18%
Cardiovascular Function and Risk Factors
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Erianin mitigates diabetic cardiomyopathy <i>via</i> adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation — Xuming Dai, Zijiao Quan, et al. · World Journal of Diabetes (2025) | TGRS Research Map | TGRS